Acta Neuropathologica

, Volume 124, Issue 2, pp 285–291 | Cite as

TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1/SPG6 mutation

  • Maria Martinez-Lage
  • Laura Molina-Porcel
  • Dana Falcone
  • Leo McCluskey
  • Virginia M.-Y. Lee
  • Vivianna M. Van Deerlin
  • John Q. Trojanowski
Case Reports

Abstract

Mutations in NIPA1 (non-imprinted in Prader–Willi/Angelman syndrome) have been described as a cause of autosomal dominant hereditary spastic paraplegia (HSP) known as SPG6 (spastic paraplegia-6). We present the first neuropathological description of a patient with a NIPA1 mutation, and clinical phenotype of complicated HSP with motor neuron disease-like syndrome and cognitive decline. Postmortem examination revealed degeneration of lateral corticospinal tracts and dorsal columns with motor neuron loss. TDP-43 immunostaining showed widespread spinal cord and cerebral skein-like and round neuronal cytoplasmic inclusions. We ruled out NIPA1 mutations in 419 additional cases of motor neuron disease. These findings suggest that hereditary spastic paraplegia due to NIPA1 mutations could represent a TDP-43 proteinopathy.

Notes

Acknowledgments

The authors would like to acknowledge Robert Greene and Amanda Piarulli for their technical support in the genotyping process and Subhojit Roy and Mark Forman for the initial neuropathological evaluation of this case. The authors are grateful to the patient and her family for their generosity.

References

  1. 1.
    Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, Rogelj B, Al-Chalabi A, Hortobagyi T, Shaw CE (2011) p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol 122(6):691–702. doi: 10.1007/s00401-011-0911-2 PubMedCrossRefGoogle Scholar
  2. 2.
    Behan WM, Maia M (1974) Strumpell’s familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry 37(1):8–20PubMedCrossRefGoogle Scholar
  3. 3.
    Bien-Willner R, Sambuughin N, Holley H, Bodensteiner J, Sivakumar K (2006) Childhood-onset spastic paraplegia with NIPAL gene mutation. J Child Neurol 21(11):974–977PubMedCrossRefGoogle Scholar
  4. 4.
    Blauw HM, Al-Chalabi A, Andersen PM, van Vught PW, Diekstra FP, van Es MA, Saris CG, Groen EJ, van Rheenen W, Koppers M, Van’t Slot R, Strengman E, Estrada K, Rivadeneira F, Hofman A, Uitterlinden AG, Kiemeney LA, Vermeulen SH, Birve A, Waibel S, Meyer T, Cronin S, McLaughlin RL, Hardiman O, Sapp PC, Tobin MD, Wain LV, Tomik B, Slowik A, Lemmens R, Rujescu D, Schulte C, Gasser T, Brown RH Jr, Landers JE, Robberecht W, Ludolph AC, Ophoff RA, Veldink JH, van den Berg LH (2010) A large genome scan for rare CNVs in amyotrophic lateral sclerosis. Hum Mol Genet 19(20):4091–4099PubMedCrossRefGoogle Scholar
  5. 5.
    Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL 3rd, Schneider JA, Kretzschmar HA, Carter D, Taylor-Reinwald L, Paulsmeyer K, Strider J, Gitcho M, Goate AM, Morris JC, Mishra M, Kwong LK, Stieber A, Xu Y, Forman MS, Trojanowski JQ, Lee VM, Mackenzie IR (2007) TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171(1):227–240. doi: 10.2353/ajpath.2007.070182 PubMedCrossRefGoogle Scholar
  6. 6.
    Chen S, Song C, Guo H, Xu P, Huang W, Zhou Y, Sun J, Li CX, Du Y, Li X, Liu Z, Geng D, Maxwell PH, Zhang C, Wang Y (2005) Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families. Hum Mutat 25(2):135–141. doi: 10.1002/humu.20126 PubMedCrossRefGoogle Scholar
  7. 7.
    Dejesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R (2011) Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron 72(2):245–256. doi: 10.1016/j.neuron.2011.09.011 PubMedCrossRefGoogle Scholar
  8. 8.
    Du J, Hu YC, Tang BS, Chen C, Luo YY, Zhan ZX, Zhao GH, Jiang H, Xia K, Shen L (2011) Expansion of the phenotypic spectrum of SPG6 caused by mutation in NIPA1. Clin Neurol Neurosurg 113(6):480–482PubMedCrossRefGoogle Scholar
  9. 9.
    Farrer MJ, Hulihan MM, Kachergus JM, Dachsel JC, Stoessl AJ, Grantier LL, Calne S, Calne DB, Lechevalier B, Chapon F, Tsuboi Y, Yamada T, Gutmann L, Elibol B, Bhatia KP, Wider C, Vilarino-Guell C, Ross OA, Brown LA, Castanedes-Casey M, Dickson DW, Wszolek ZK (2009) DCTN1 mutations in Perry syndrome. Nat Genet 41(2):163–165. doi: 10.1038/ng.293 PubMedCrossRefGoogle Scholar
  10. 10.
    Fink JK (2006) Hereditary spastic paraplegia. Curr Neurol Neurosci Rep 6(1):65–76PubMedCrossRefGoogle Scholar
  11. 11.
    Fink JK, Wu CT, Jones SM, Sharp GB, Lange BM, Lesicki A, Reinglass T, Varvil T, Otterud B, Leppert M (1995) Autosomal dominant familial spastic paraplegia: tight linkage to chromosome 15q. Am J Hum Genet 56(1):188–192PubMedGoogle Scholar
  12. 12.
    Geser F, Martinez-Lage M, Robinson J, Uryu K, Neumann M, Brandmeir NJ, Xie SX, Kwong LK, Elman L, McCluskey L, Clark CM, Malunda J, Miller BL, Zimmerman EA, Qian J, Van Deerlin V, Grossman M, Lee VM, Trojanowski JQ (2009) Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol 66(2):180–189. doi: 10.1001/archneurol.2008.558 PubMedCrossRefGoogle Scholar
  13. 13.
    Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet 1(8334):1151–1155 (pii:S0140-6736(83)92879-9)PubMedCrossRefGoogle Scholar
  14. 14.
    Ito H, Nakamura M, Komure O, Ayaki T, Wate R, Maruyama H, Nakamura Y, Fujita K, Kaneko S, Okamoto Y, Ihara M, Konishi T, Ogasawara K, Hirano A, Kusaka H, Kaji R, Takahashi R, Kawakami H (2011) Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation. Acta Neuropathol 122(2):223–229. doi: 10.1007/s00401-011-0842-y PubMedCrossRefGoogle Scholar
  15. 15.
    Kaneko S, Kawarai T, Yip E, Salehi-Rad S, Sato C, Orlacchio A, Bernardi G, Liang Y, Hasegawa H, Rogaeva E, St George-Hyslop P (2006) Novel SPG6 mutation p.A100T in a Japanese family with autosomal dominant form of hereditary spastic paraplegia. Mov Disord 21(9):1531–1533Google Scholar
  16. 16.
    Klebe S, Lacour A, Durr A, Stojkovic T, Depienne C, Forlani S, Poea-Guyon S, Vuillaume I, Sablonniere B, Vermersch P, Brice A, Stevanin G (2007) NIPA1 (SPG6) mutations are a rare cause of autosomal dominant spastic paraplegia in Europe. Neurogenetics 8(2):155–157PubMedCrossRefGoogle Scholar
  17. 17.
    Kuru S, Sakai M, Konagaya M, Yoshida M, Hashizume Y (2005) Autopsy case of hereditary spastic paraplegia with thin corpus callosum showing severe gliosis in the cerebral white matter. Neuropathology 25(4):346–352PubMedCrossRefGoogle Scholar
  18. 18.
    Liu SG, Zhao JJ, Zhuang MY, Li FF, Zhang QJ, Huang SZ, Che FY, de Lu G, Liu SE, Teng JJ, Ma X (2008) Clinical and genetic study of SPG6 mutation in a Chinese family with hereditary spastic paraplegia. J Neurol Sci 266(1–2):109–114PubMedCrossRefGoogle Scholar
  19. 19.
    Mackenzie IR (2007) The neuropathology and clinical phenotype of FTD with progranulin mutations. Acta Neuropathol 114(1):49–54. doi: 10.1007/s00401-007-0223-8 PubMedCrossRefGoogle Scholar
  20. 20.
    Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122(1):111–113. doi: 10.1007/s00401-011-0845-8 PubMedCrossRefGoogle Scholar
  21. 21.
    Meyer T, Schwan A, Dullinger JS, Brocke J, Hoffmann KT, Nolte CH, Hopt A, Kopp U, Andersen P, Epplen JT, Linke P (2005) Early-onset ALS with long-term survival associated with spastin gene mutation. Neurology 65(1):141–143. doi: 10.1212/01.wnl.0000167130.31618.0a PubMedCrossRefGoogle Scholar
  22. 22.
    Munhoz RP, Kawarai T, Teive HA, Raskin S, Sato C, Liang Y, St George-Hyslop PH, Rogaeva E (2006) Clinical and genetic study of a Brazilian family with spastic paraplegia (SPG6 locus). Mov Disord 21(2):279–281. doi: 10.1002/mds.20775 PubMedCrossRefGoogle Scholar
  23. 23.
    Murray ME, DeJesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR, Wszolek ZK, Ferman TJ, Josephs KA, Boylan KB, Rademakers R, Dickson DW (2011) Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol 122(6):673–690. doi: 10.1007/s00401-011-0907-y PubMedCrossRefGoogle Scholar
  24. 24.
    Neumann M, Mackenzie IR, Cairns NJ, Boyer PJ, Markesbery WR, Smith CD, Taylor JP, Kretzschmar HA, Kimonis VE, Forman MS (2007) TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol 66(2):152–157. doi: 10.1097/nen.0b013e31803020b9 PubMedCrossRefGoogle Scholar
  25. 25.
    Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130–133. doi: 10.1126/science.1134108 PubMedCrossRefGoogle Scholar
  26. 26.
    Nomura H, Koike F, Tsuruta Y, Iwaki A, Iwaki T (2001) Autopsy case of autosomal recessive hereditary spastic paraplegia with reference to the muscular pathology. Neuropathology 21(3):212–217PubMedCrossRefGoogle Scholar
  27. 27.
    Orlacchio A, Babalini C, Borreca A, Patrono C, Massa R, Basaran S, Munhoz RP, Rogaeva EA, St George-Hyslop PH, Bernardi G, Kawarai T (2010) SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain 133(2):591–598. doi: 10.1093/brain/awp325 PubMedCrossRefGoogle Scholar
  28. 28.
    Rainier S, Chai JH, Tokarz D, Nicholls RD, Fink JK (2003) NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am J Hum Genet 73(4):967–971PubMedCrossRefGoogle Scholar
  29. 29.
    Reed JA, Wilkinson PA, Patel H, Simpson MA, Chatonnet A, Robay D, Patton MA, Crosby AH, Warner TT (2005) A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegia. Neurogenetics 6(2):79–84PubMedCrossRefGoogle Scholar
  30. 30.
    Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, Holtta-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chio A, Restagno G, Borghero G, Sabatelli M, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ (2011) A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron 72(2):257–268. doi: 10.1016/j.neuron.2011.09.010 PubMedCrossRefGoogle Scholar
  31. 31.
    Seilhean D, Cazeneuve C, Thuries V, Russaouen O, Millecamps S, Salachas F, Meininger V, Leguern E, Duyckaerts C (2009) Accumulation of TDP-43 and alpha-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation. Acta Neuropathol 118(4):561–573. doi: 10.1007/s00401-009-0545-9 PubMedCrossRefGoogle Scholar
  32. 32.
    Svenstrup K, Moller RS, Christensen J, Budtz-Jorgensen E, Gilling M, Nielsen JE (2011) NIPA1 mutation in complex hereditary spastic paraplegia with epilepsy. Eur J Neurol 18(9):1197-1199. doi: 10.1111/j.1468-1331.2011.03359.x Google Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Maria Martinez-Lage
    • 2
  • Laura Molina-Porcel
    • 2
  • Dana Falcone
    • 2
  • Leo McCluskey
    • 3
  • Virginia M.-Y. Lee
    • 2
  • Vivianna M. Van Deerlin
    • 1
  • John Q. Trojanowski
    • 2
  1. 1.Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research (CNDR)University of Pennsylvania Health SystemPhiladelphiaUSA
  2. 2.Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research (CNDR)University of Pennsylvania Health SystemPhiladelphiaUSA
  3. 3.Department of NeurologyUniversity of Pennsylvania Health SystemPhiladelphiaUSA

Personalised recommendations